Skip to main content

Table 1 Summary of studies included (N = 24)

From: Reproductive justice in the time of COVID-19: a systematic review of the indirect impacts of COVID-19 on sexual and reproductive health

Characteristic n (%)
Study design  
 Quantitative 22 (91.7)
 Cross-sectional 13 (54.2)
 Longitudinal 3 (12.5)
 Quasi-experimental 2 (8.3)
 Retrospective 4 (16.7)
 Mixed methods 2 (8.3)
Sample size  
 None given 1 (4.2)
 1–100 7 (29.2)
 101–1000 10 (41.6)
 > 1000 6 (25.0)
Region (as defined by WHO)  
 Africa 1 (4.2)
 Americas 11 (45.8)
 South-East Asia 1 (4.2)
 Europe 5 (20.8)
 Eastern Mediterranean 0 (0.0)
 Western Pacific 2 (8.3)
 Global 2 (8.3)
Respiratory epidemic  
 COVID-19 24 (100)
Primary SRH outcomea  
 Abortion 8 (33.3)
 Contraceptive access/utilization 5 (20.8)
 Menstruation 2 (8.3)
 Service provision 6 (25.0)
 Sexual behavior 4 (16.7)
 Pregnancy intentions 3 (12.5)
QATSDD  
 High 10 (41.7)
 Low 14 (58.3)
  1. SRH sexual and reproductive health; COVID-19 coronavirus disease 2019, WHO World Health Organization; QATSDD Quality Assessment Tool for Studies with Diverse Designs
  2. aMay not equate to 100% due to multiple outcomes